Timothy Chiang
Stock Analyst at Capital One
(1.13)
# 3,833
Out of 5,113 analysts
5
Total ratings
20%
Success rate
0.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Timothy Chiang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Initiates: Overweight | n/a | $82.99 | - | 1 | Mar 15, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $55 | $83.10 | -33.81% | 2 | Feb 11, 2022 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Outperform | n/a | $25.92 | - | 1 | Oct 5, 2020 | |
| IDYA IDEAYA Biosciences | Initiates: Outperform | $28 | $34.80 | -19.54% | 1 | Sep 1, 2020 |
ANI Pharmaceuticals
Mar 15, 2024
Initiates: Overweight
Price Target: n/a
Current: $82.99
Upside: -
Protagonist Therapeutics
Feb 11, 2022
Initiates: Buy
Price Target: $55
Current: $83.10
Upside: -33.81%
Amphastar Pharmaceuticals
Oct 5, 2020
Upgrades: Outperform
Price Target: n/a
Current: $25.92
Upside: -
IDEAYA Biosciences
Sep 1, 2020
Initiates: Outperform
Price Target: $28
Current: $34.80
Upside: -19.54%